Comparison of the Short Test of Mental Status and the Montreal Cognitive Assessment Across the Cognitive Spectrum.


Journal

Mayo Clinic proceedings
ISSN: 1942-5546
Titre abrégé: Mayo Clin Proc
Pays: England
ID NLM: 0405543

Informations de publication

Date de publication:
08 2019
Historique:
received: 28 08 2018
revised: 18 12 2018
accepted: 04 01 2019
pubmed: 10 7 2019
medline: 10 1 2020
entrez: 9 7 2019
Statut: ppublish

Résumé

To compare the Short Test of Mental Status (STMS) with the Montreal Cognitive Assessment (MoCA) for predicting and detecting mild cognitive impairment (MCI). Participants from the community-based Mayo Clinic Study of Aging (MCSA) (November 24, 2010, through May 19, 2012) and an academic referral Alzheimer's Disease Research Center (ADRC) (March 16, 2015, through September 5, 2018) were analyzed. All participants were evaluated using a standardized neuropsychological battery, and a multidisciplinary consensus diagnosis was assigned. The MCSA and ADRC samples included 313 and 106 stable cognitively normal (CN) participants, 72 and 8 CN participants at baseline who developed incident MCI or dementia, 114 and 96 participants with prevalent MCI, and 25 and 132 participants with dementia, respectively. There were no statistically significant differences between the 2 tests in 6 of 7 diagnostic comparisons across academic referral and community populations. The STMS had a better area under the curve (0.90; 95% CI, 0.87-0.93) for differentiating prevalent MCI from CN participants in the MCSA cohort compared with the MoCA cohort (0.85; 95% CI, 0.81-0.89; P=.01). In addition, 53% of the stable CN participants (222 of 419) scored less than 26 on the MoCA, with specificity of 47% for diagnosing prevalent MCI. We provide evidence that the STMS performs similarly to the MoCA in a variety of settings and neurodegenerative syndromes. These results suggest that the current recommended MoCA cutoff score may be overly sensitive, consistent with previous studies. We also provide a conversion table for comparing the 2 cognitive tests.

Identifiants

pubmed: 31280871
pii: S0025-6196(19)30215-0
doi: 10.1016/j.mayocp.2019.01.043
pmc: PMC6937135
mid: NIHMS1523550
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1516-1523

Subventions

Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG006786
Pays : United States

Informations de copyright

Copyright © 2019 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Références

Alzheimer Dis Assoc Disord. 2013 Jan-Mar;27(1):37-43
pubmed: 22193353
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Neurology. 1992 Feb;42(2):396-401
pubmed: 1736173
J Am Geriatr Soc. 2017 May;65(5):1067-1072
pubmed: 28205215
N Engl J Med. 2011 Dec 29;365(26):2447-9
pubmed: 22204721
Lancet. 2006 Apr 15;367(9518):1262-70
pubmed: 16631882
Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):134-9
pubmed: 26485498
PLoS Med. 2012 Oct;9(10):e1001331
pubmed: 23118618
Brain. 2011 Sep;134(Pt 9):2456-77
pubmed: 21810890
Neurology. 2011 Sep 27;77(13):1272-5
pubmed: 21917776
Arch Neurol. 2003 Dec;60(12):1777-81
pubmed: 14676056
Lancet. 2009 Jun 13;373(9680):2009-10
pubmed: 19362360
Int Psychogeriatr. 2012 Mar;24(3):391-6
pubmed: 22014176
J Neurol Sci. 2010 Dec 15;299(1-2):15-8
pubmed: 20889166
Neurology. 2009 Nov 24;73(21):1738-45
pubmed: 19933974
Mayo Clin Proc. 2012 Dec;87(12):1202-13
pubmed: 23199802
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(6):755-61
pubmed: 25942388
J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):790-9
pubmed: 17178826
Arch Neurol. 1991 Jul;48(7):725-8
pubmed: 1859300
Aging (Milano). 1990 Dec;2(4):408-15
pubmed: 2094381
Dement Geriatr Cogn Disord. 2011;31(2):126-31
pubmed: 21282950
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Int J Geriatr Psychiatry. 2012 Nov;27(11):1189-94
pubmed: 22228412
Int J Epidemiol. 2012 Dec;41(6):1614-24
pubmed: 23159830
J Clin Exp Neuropsychol. 2012;34(7):750-7
pubmed: 22468719
Mayo Clin Proc. 1987 Apr;62(4):281-8
pubmed: 3561043
Int J Geriatr Psychiatry. 2009 Feb;24(2):197-201
pubmed: 18850670
J Am Geriatr Soc. 2003 Feb;51(2):277-8
pubmed: 12558730
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250

Auteurs

Ryan A Townley (RA)

Department of Neurology, Mayo Clinic, Rochester, MN. Electronic address: Townley.Ryan@mayo.edu.

Jeremy A Syrjanen (JA)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

Hugo Botha (H)

Department of Neurology, Mayo Clinic, Rochester, MN.

Walter K Kremers (WK)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

Jeremiah A Aakre (JA)

Department of Health Sciences Research, Mayo Clinic, Rochester, MN.

Julie A Fields (JA)

Department of Psychology and Psychiatry, Mayo Clinic, Rochester, MN.

Mary M Machulda (MM)

Department of Psychology and Psychiatry, Mayo Clinic, Rochester, MN.

Jonathan Graff-Radford (J)

Department of Neurology, Mayo Clinic, Rochester, MN.

Rodolfo Savica (R)

Department of Neurology, Mayo Clinic, Rochester, MN.

David T Jones (DT)

Department of Neurology, Mayo Clinic, Rochester, MN.

David S Knopman (DS)

Department of Neurology, Mayo Clinic, Rochester, MN.

Ronald C Petersen (RC)

Department of Neurology, Mayo Clinic, Rochester, MN.

Bradley F Boeve (BF)

Department of Neurology, Mayo Clinic, Rochester, MN.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH